We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

CERVICAL CANCER DIAGNOSTIC TESTS MARKET ANALYSIS

Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, Endocervical Curettage Test, and HPV Test), By Age Group (Age 20–40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

  • Published In : Jul 2023
  • Code : CMI3994
  • Pages :220
  • Formats :
      Excel and PDF
  • Industry : Clinical Diagnostic

Cervical Cancer Diagnostic Tests MarketSize and Trends

Global cervical cancer diagnostic tests market is estimated to be valued at US$ 7.04 Billion in 2023 and is expected to exhibit a CAGR of 6.3% during the forecast period (2023-2030).

Over the projected period, increased teenage sexual activity, rising incidence of cervical cancer, and high prevalence of (human papillomavirus) HPV-infected individuals are anticipated to drive the growth of the global market for cervical cancer diagnostic tests. For instance, in February 02, 2023, according to the American Society of Clinical Oncology (ASCO), globally an estimated 604,127 women were diagnosed with cervical cancer in 2020 and about 341,831 women worldwide died from cervical cancer.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.